- Apakah ganja akan dijadwalkan ulang sebelum 31 Desember?11¢11%
The DEA administrative process for moving botanical marijuana from Schedule I to Schedule III remains in a limited briefing phase following an October 22 order from Chief ALJ Derek Julius. That ruling admitted a September GAO report highlighting gaps in federal scheduling procedures but denied requests to reopen the June-July 2026 hearings for additional testimony. Optional briefs on the report’s weight are due by November 5, after which the stay lifts and the judge can issue a nonbinding recommendation. An April 2026 Attorney General order already placed state-licensed medical marijuana and FDA-approved products into Schedule III, with the DEA issuing initial federal registrations to over 900 dispensaries in seven states as the first implementation step. Broader rescheduling covering adult-use cannabis requires the full hearing record, agency decision, and potential further review, keeping near-term resolution unlikely.
Aturan
Pasar ini akan diputuskan sebagai "Ya" jika Drug Enforcement Administration Amerika Serikat (https://www.dea.gov/drug-information/drug-scheduling) menurunkan klasifikasi ganja dari Tingkat I ke tingkat lainnya (atau sepenuhnya menghapusnya dari daftar zat terkontrol) paling lambat 31 Desember 2026, 23.59 ET. Jika tidak, pasar ini akan diselesaikan dengan hasil "Tidak". Sumber utama untuk penyelesaian pasar ini adalah informasi resmi dari pemerintah AS; namun, konsensus dari pemberitaan yang kredibel juga akan digunakan.
Terjemahan mesin. Jika ada perselisihan, teks asli yang berlaku.